Nutrition researchers have spent decades building a case for a plant that most North Americans overlook entirely. Guava ...
AbbVie (NYSE: ABBV) today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting ...